A Conversation with Mark Sell, MD Logistics

In an earlier era in the US pharma industry, “supply chain” and “logistics” were an afterthought. Pharma companies maintained large warehouses; stocked lots of product; and basically pushed product out wherever it needed to be, ensuring that a prescription would always be filled whenever the scrip arrived at a pharmacy. For most of this century, Read the full article…

Innovations and Adaptations in the Cold Chain

The rise of targeted therapies and the globalization of specialty pharmaceutical commercialization present a host of opportunities for manufacturers. The foundational premise is clear: More commercial and clinical trial drugs are being shipped to more patients in more countries than ever before. Healthcare is becoming more innovative and more accessible at the same time. Read the full article…

White Paper: Getting Serious About Serialization, The Drug Quality and Security Act

On Nov. 27, 2013 President Obama signed the Drug Quality and Security Act into law, effectively setting the framework of what would become a nationwide initiative toward wide-scale pharmaceutical serialization. The Drug Supply Chain Security Act is one component of the DQSA. This particular act requires the FDA to implement a national track-and-trace system by which manufacturers must affix product identifiers (barcodes) to each package of product that is introduced into the supply chain. Read the full article…

MD Logistics Sponsors Leading Cold Chain Forum

MD Logistics is proud to support a leading event in the life science industry for cold storage and third party logistics providers – the 13th annual Cold Chain GDP & Temperature Management Logistics Global Forum, taking place in Boston October 5 to 9, 2015. The global cold chain forum brings together more than 800 of the Read the full article…

The Big Chill: 10 Trends in Cold Chain Logistics

With its capital-intensive equipment, strict temperature requirements, and energy dependence, the cold chain has always been a demanding logistics segment. Now the sector is grappling with additional challenges—from increases in the sensitivity, quality standards, and volume of many of its goods, to continually mounting regulations. Read the full article…